These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 11151032

  • 1. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice.
    Petricevich VL, Ueda C, Alves RC, da Silva MA, Moreno C, Melo AR, Dias da Silva W.
    Braz J Med Biol Res; 2001 Jan; 34(1):81-92. PubMed ID: 11151032
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, Slobbe L, Collins DM, de Lisle GW, Buddle BM.
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH, Sun Z, Yang XL, Bao L.
    Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
    [Abstract] [Full Text] [Related]

  • 6. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
    Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M.
    Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M, Dobakhti F, Pakzad SR, Ajdary S.
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH, He HY, Zhang FJ.
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [Abstract] [Full Text] [Related]

  • 10. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A, Hur YG, Gu S, Cho SN.
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ, Chen X, Hu T, Meng C, Wang XB, Rao Y, Zhang XM, Yin YL, Pan ZM, Jiao XA.
    Front Cell Infect Microbiol; 2016 Nov; 6():3. PubMed ID: 26858942
    [Abstract] [Full Text] [Related]

  • 12. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine.
    Ding Y, Zheng H, Feng C, Wang B, Liu C, Mi K, Cao H, Meng S.
    Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661
    [Abstract] [Full Text] [Related]

  • 13. Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice.
    Christy AJ, Dharman K, Dhandapaani G, Palaniyandi K, Gupta UD, Gupta P, Ignacimuthu S, Narayanan S.
    Vaccine; 2012 Feb 08; 30(7):1364-70. PubMed ID: 22200502
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice.
    Bonanni D, Rindi L, Lari N, Garzelli C.
    J Med Microbiol; 2005 May 08; 54(Pt 5):443-448. PubMed ID: 15824420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.
    Eur J Immunol; 2008 Mar 08; 38(3):695-705. PubMed ID: 18266274
    [Abstract] [Full Text] [Related]

  • 17. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ, Kursar M, Kaufmann SH.
    J Infect Dis; 2004 Aug 01; 190(3):588-97. PubMed ID: 15243936
    [Abstract] [Full Text] [Related]

  • 18. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin.
    Young S, O'Donnell M, Lockhart E, Buddle B, Slobbe L, Luo Y, De Lisle G, Buchan G.
    Immunol Cell Biol; 2002 Jun 01; 80(3):209-15. PubMed ID: 12067407
    [Abstract] [Full Text] [Related]

  • 19. The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.
    Oliveira FM, Trentini MM, Junqueira-Kipnis AP, Kipnis A.
    Mem Inst Oswaldo Cruz; 2016 Apr 01; 111(4):223-31. PubMed ID: 27074251
    [Abstract] [Full Text] [Related]

  • 20. Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra.
    Sinha RK, Verma I, Khuller GK.
    Vaccine; 1997 Apr 01; 15(6-7):689-99. PubMed ID: 9178471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.